Haleon plc (NYSE:HLN) Receives $12.33 Average PT from Analysts

Shares of Haleon plc (NYSE:HLN) have earned a consensus recommendation of “Moderate Buy” from the eleven brokerages that are covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating, four have issued a buy rating and two have issued a strong buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $12.33.

Several research firms have weighed in on HLN. BNP Paribas Exane raised Haleon from a “neutral” rating to an “outperform” rating and set a $13.40 target price on the stock in a research note on Tuesday, May 27th. Morgan Stanley upgraded shares of Haleon from an “equal weight” rating to an “overweight” rating and set a $11.25 price target on the stock in a research report on Friday, May 9th. HSBC reiterated a “hold” rating on shares of Haleon in a report on Wednesday, March 5th. Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Finally, Wall Street Zen raised Haleon from a “hold” rating to a “buy” rating in a research note on Friday, June 6th.

Institutional Investors Weigh In On Haleon

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Brighton Jones LLC acquired a new stake in shares of Haleon in the 4th quarter valued at about $187,000. Spire Wealth Management acquired a new stake in Haleon in the 4th quarter valued at approximately $39,000. Bleakley Financial Group LLC raised its position in Haleon by 24.6% in the 4th quarter. Bleakley Financial Group LLC now owns 14,784 shares of the company’s stock valued at $141,000 after buying an additional 2,921 shares during the last quarter. Strategic Financial Concepts LLC acquired a new stake in Haleon in the 4th quarter valued at approximately $847,000. Finally, Wilmington Savings Fund Society FSB raised its position in Haleon by 19.0% in the 4th quarter. Wilmington Savings Fund Society FSB now owns 22,858 shares of the company’s stock valued at $218,000 after buying an additional 3,647 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Stock Performance

HLN stock opened at $10.72 on Tuesday. The business’s fifty day moving average is $10.63 and its 200-day moving average is $10.09. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The company has a market cap of $48.23 billion, a P/E ratio of 31.51, a price-to-earnings-growth ratio of 2.82 and a beta of 0.31. Haleon has a twelve month low of $8.25 and a twelve month high of $11.42.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.